Skip to main content

Table 2 Baseline demographic and clinical characteristics of the discrepant/overlapping group

From: Tau levels are higher in objective subtle cognitive decline but not subjective memory complaint

 

SMC−/Obj-SCD−

SMC+/Obj-SCD−

SMC−/Obj-SCD+

SMC+/Obj-SCD+

F or χ2

p

N

57

116

20

43

  

Age, mean (SD)

70.10 (5.51)

71.14 (6.86)

69.72 (5.94)

71.42 (5.56)

F = 0.69

0.560

Education, mean (SD)

17.16 (2.02)

16.64 (2.20)

16.90 (2.38)

17.02 (2.39)

F = 0.82

0.486

Female/woman, %

63.2%

57.8%

50.0%

51.2%

χ2 = 1.91

0.592

Race, %

    

χ2 = 11.64

0.475

 American Indian/Alaska Native

1.8%

0.0%

0.0%

0.0%

  

 Asian

0.0%

1.7%

5.0%

2.3%

  

 Black

0.0%

3.4%

5.0%

4.7%

  

 White

98.2%

90.5%

90.0%

90.7%

  

 More than one

0.0%

4.3%

0.0%

2.3%

  

Ethnicity, %

    

χ2 = 6.37

0.383

 Hispanic/Latino

0.0%

4.3%

0.0%

0.0%

  

 Non-Hispanic/non-Latino

100.0%

94.8%

100.0%

100.0%

  

 Unknown

0.0%

0.9%

0.0%

0.0%

  

Pulse pressure, mean (SD)

56.23 (12.80)

55.03 (16.29)

59.55 (20.38)

53.37 (15.61)

F = 0.77

0.512

APOE ε4 carrier, %

29.8%

40.5%

30.0%

34.9%

χ2 = 2.31

0.511

GDS, mean (SD)

0.39 (0.68)ac

0.87 (1.16)d

0.45 (0.69)a

1.09 (1.43)bd

F = 4.52

0.004

CCI, mean (SD)

13.47 (1.20)ac

21.89 (6.45)abd

13.80 (1.32)ac

24.51 (7.89)bcd

F = 45.90

< 0.001

PACC, mean (SD)

1.39 (1.99)abc

0.43 (2.47)ad

− 0.71 (3.16)d

− 1.72 (3.15)cd

F = 12.67

< 0.001

Tau PET, mean (SD)

1.42 (0.13)

1.42 (0.13)

1.49 (0.28)

1.45 (0.13)

F = 1.61

0.187

Aβ PETe, mean (SD)

17.01 (27.30)

24.00 (31.18)

25.47 (30.69)

21.21 (32.60)

F = 0.77

0.512

Aβ PET positivity, %

26.3%

37.9%

40.0%

33.3%

F = 2.59

0.460

  1. SMC subjective memory complaint, Obj-SCD objective subtle cognitive decline, APOE apolipoprotein E, GDS Geriatric Depression Scale, CCI Cognitive Change Index, PACC Modified Preclinical Alzheimer Cognitive Composite, Tau PET Braak III/IV SUVR, Aβ PET β-amyloid cortical SUVR in centiloids, F statistic reported for one-way ANOVAs, χ2 statistic report for chi-square tests
  2. aSignificantly different from SMC+/Obj-SCD+
  3. bSignificantly different from SMC−/Obj-SCD+
  4. cSignificantly different from SMC+/Obj-SCD−
  5. dSignificantly different from SMC−/Obj-SCD−
  6. e1 SMC+/Obj-SCD+ participant is missing Aβ PET data